GlassScriptPhysician profile
Ann Rogerson
NPI 1770953317
$4,369.14
in general payments reported to CMS, 2019-2025
20 companies · $825 in 2025
The $825 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $899 · 2022: $1,167 · 2023: $556 · 2024: $921 · 2025: $825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,216 · Travel and Lodging: $1,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,216.12 |
| Travel and Lodging | $1,086.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,453.05 | 2021-2025 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $405.97 | 2023-2024 | |
| Boston Scientific Corporation | $364.90 | 2021-2025 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $334.67 | 2021-2023 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $282.40 | 2021-2023 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $282.17 | 2021-2023 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $275.03 | 2021-2022 | |
| Pfizer INC. | $246.02 | 2021-2023 | |
| Amgen INC. | $238.88 | 2021-2025 | Repatha |
| Medtronic, INC. | $174.49 | 2024 | Corevalve Evolut R |
| Esperion Therapeutics, INC. | $136.00 | 2021 | |
| Heartflow, INC. | $35.15 | 2023 | Ffrct |
| Amarin Pharma, INC. | $25.84 | 2022 | |
| Edwards Lifesciences Corporation | $18.39 | 2024 | |
| Amryt Pharma Holdings LTD | $17.74 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $17.58 | 2023 | Arcalyst |
| Genzyme Corporation | $16.12 | 2021 | |
| Irhythm Technologies, INC. | $15.93 | 2022 | |
| Merck Sharp & Dohme LLC | $15.66 | 2022 | |
| Biotronik INC. | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Rogerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.